CME's Duffy Highlights Overlooked Tax Risk Associated with US Perpetual Futures

The approval of perpetual futures contracts in the US may lead to unforeseen tax and regulatory issues for traders if these products are ultimately classified as swaps instead of futures, warns CME Group Chairman and CEO Terry Duffy. In an interview, Duffy noted that there is ambiguity surrounding the tax implications for US participants due to the lack of clarity on whether perpetual futures should be considered swaps or futures. This ambiguity stems from the periodic funding payments exchanged between long and short positions in perpetual contracts, which Duffy believes aligns with the statutory definition of a swap under US law. If perpetual contracts are deemed swaps, they would be subject to ordinary taxation, as opposed to the blended tax treatment available for futures under Section 1256 of the US tax code. However, the IRS has not provided specific guidance on the tax treatment of perpetual futures, leaving market participants uncertain about how to report their positions. Legal experts agree that the issue is complex, with the definition of swaps being extremely broad and open to interpretation. The outcome of the ongoing legal battle between CME and the CFTC over the approval of perpetual futures contracts will significantly influence the tax treatment of these products and may lead to further litigation.